71/100BIQVIA Holdings stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for IQVIA Holdings is 291.33, 10.0% above the current price of 264.96. Their targets range from 240.00 to 346.00.
Of the 14 firms that rated IQVIA Holdings in the past 12 months, 12 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 240.00 to 346.00, with an average of 291.33.
| Buy | 12 | |
| Hold | 2 | |
| Sell | 0 |
12-month price target
| Highest target | 346.00 |
| Average target | 291.33 |
| Lowest target | 240.00 |
| Current price | 264.96 |
IQVIA Holdings price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their IQVIA Holdings price target and rating?
How analysts rate IQVIA Holdings, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 14 firms rate it buy now, against 11 of 14 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
IQVIA Holdings analyst upgrades, downgrades and price targets
The latest rating change came on 17 June 2026, when Morgan Stanley downgraded IQVIA Holdings from Overweight to Equal Weight. Its price target is 200.00, from 225.00. The most recent new target came from TD Cowen on 29 October 2026: 307.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 29 Oct 2026 | TD Cowen Charles Rhyee | Reiterated · Buy | 307.00 | — | 275.06 |
| 28 Oct 2026 | Truist Financial Jailendra Singh | Reiterated · Buy | 329.00 → 346.00 | +5.2% | 280.82 |
| 27 Oct 2026 | Robert W. Baird | — | 287.00 → 328.00 | +14.3% | 271.53 |
| 14 Oct 2026 | Stifel Nicolaus | Reiterated · Buy | 220.00 → 303.00 | +37.7% | 260.71 |
| 7 Oct 2026 | Mizuho Securities | Reiterated · Outperform | 230.00 → 300.00 | +30.4% | 260.16 |
| 7 Oct 2026 | Barclays Luke Sergott | Reiterated · Overweight | 210.00 → 300.00 | +42.9% | 260.16 |
| 30 Sept 2026 | UBS | — | 240.00 → 345.00 | +43.8% | 269.19 |
| 28 Sept 2026 | Truist Financial | Reiterated · Buy | 245.00 → 329.00 | +34.3% | 270.37 |
| 17 Sept 2026 | Morgan Stanley | Reiterated · Equal Weight | 200.00 → 270.00 | +35.0% | 268.82 |
| 29 Jul 2026 | RBC Capital | Reiterated · Outperform | 247.00 | — | 246.03 |
| 29 Jul 2026 | BMO Capital Sean Dodge | Reiterated · Outperform | 250.00 → 270.00 | +8.0% | 249.51 |
| 29 Jul 2026 | Robert W. Baird Eric Coldwell | — | 249.00 → 287.00 | +15.3% | 243.31 |
| 13 Jul 2026 | Mizuho Securities Ann Hynes | Reiterated · Outperform | 215.00 → 230.00 | +7.0% | 207.85 |
| 9 Jul 2026 | Deutsche Bank | — | 240.00 | — | 208.00 |
| 6 Jul 2026 | HSBC Sidharth Sahoo | — | 210.00 → 240.00 | +14.3% | 206.42 |
| 1 Jul 2026 | Robert W. Baird | — | 258.00 → 249.00 | -3.5% | 193.22 |
| 17 Jun 2026 | Morgan Stanley Kallum Titchmarsh | Downgraded · Overweight → Equal Weight | 225.00 → 200.00 | -11.1% | 179.17 |
| 3 Jun 2026 | HSBC | — | 235.00 → 210.00 | -10.6% | 180.64 |
| 7 May 2026 | Morgan Stanley | — | 240.00 → 225.00 | -6.3% | 179.31 |
| 8 Apr 2026 | Evercore ISI Elizabeth Anderson | Reiterated · Outperform | 225.00 → 185.00 | -17.8% | 172.54 |
| 9 Mar 2026 | TD Cowen | Upgraded · Hold → Buy | — | — | — |
| 6 Mar 2026 | Barclays | Upgraded · Equal Weight → Overweight | — | — | — |
| 23 Feb 2026 | Mizuho Securities | — | 266.00 → 215.00 | -19.2% | 165.62 |
| 19 Feb 2026 | Truist Financial | Reiterated · Buy | 290.00 → 245.00 | -15.5% | 165.64 |
| 11 Feb 2026 | Morgan Stanley | — | 265.00 → 240.00 | -9.4% | 178.88 |
| 6 Feb 2026 | UBS | Reiterated · Buy | 280.00 → 240.00 | -14.3% | 184.01 |
| 6 Feb 2026 | BMO Capital | — | 250.00 | — | 184.75 |
| 6 Feb 2026 | Stifel Nicolaus | Reiterated · Buy | 254.00 → 220.00 | -13.4% | 184.67 |
| 6 Feb 2026 | Barclays Luke Sergott | Reiterated · Equal Weight | 230.00 → 210.00 | -8.7% | 180.96 |
| 5 Feb 2026 | Evercore ISI Elizabeth Anderson | — | 240.00 → 225.00 | -6.3% | 180.96 |
| 9 Jan 2026 | Mizuho Securities | — | 225.00 → 266.00 | +18.2% | 243.19 |
| 8 Jan 2026 | UBS Dan Leonard | Reiterated · Buy | 250.00 → 280.00 | +12.0% | 242.66 |
| 8 Jan 2026 | Truist Financial Jailendra Singh | Reiterated · Buy | 290.00 | — | 241.10 |
| 15 Dec 2025 | Barclays | — | 200.00 → 230.00 | +15.0% | 222.26 |
| 1 Dec 2025 | Morgan Stanley | — | 265.00 | — | 228.47 |
IQVIA Holdings EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect IQVIA Holdings's EPS to grow 26.6% a year until 2028. Over the last 5 years it grew 40.5% a year, and over the last 3 years 11.1%.
Analysts expect IQVIA Holdings's revenue to grow 6.5% a year until 2028, about as fast as over the last 5 years (7.5% a year) and the last 3 years (4.2%).
Revenue
EPS
Does IQVIA Holdings beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 1.8% off the result, either way, and their revenue estimate 1.4%, over the last 12 quarters.
- EPS beats
- 53 / 55
- Revenue beats
- 54 / 55
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +1.8%
- Since
- May 2013
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 27 Oct 2026 | 3.26 | 3.34 | +2.5% | 4.37B | 4.43B | +1.4% |
| Q2 FY2026 | 28 Jul 2026 | 3.03 | 3.15 | +4.0% | 4.30B | 4.37B | +1.5% |
| Q1 FY2026 | 5 May 2026 | 2.82 | 2.90 | +2.8% | 4.10B | 4.15B | +1.2% |
| Q4 FY2025 | 5 Feb 2026 | 3.40 | 3.42 | +0.6% | 4.24B | 4.36B | +2.9% |
| Q3 FY2025 | 28 Oct 2025 | 2.98 | 3.00 | +0.7% | 4.08B | 4.10B | +0.5% |
| Q2 FY2025 | 22 Jul 2025 | 2.77 | 2.81 | +1.4% | 3.97B | 4.02B | +1.2% |
| Q1 FY2025 | 6 May 2025 | 2.63 | 2.70 | +2.7% | 3.77B | 3.83B | +1.5% |
| Q4 FY2024 | 6 Feb 2025 | 3.11 | 3.12 | +0.3% | 3.93B | 3.96B | +0.8% |
| Q3 FY2024 | 31 Oct 2024 | 2.82 | 2.84 | +0.7% | 3.87B | 3.90B | +0.8% |
| Q2 FY2024 | 22 Jul 2024 | 2.56 | 2.64 | +3.1% | 3.79B | 3.81B | +0.6% |
| Q1 FY2024 | 2 May 2024 | 2.49 | 2.54 | +2.0% | 3.70B | 3.74B | +1.0% |
| Q4 FY2023 | 14 Feb 2024 | 2.82 | 2.84 | +0.7% | 3.80B | 3.91B | +3.0% |
IQVIA Holdings stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If IQVIA Holdings's earnings keep growing at the 10.1% a year analysts expect to FY2028, it would earn about 19.29 a share in FY2030. At the P/E it has traded at over the last five years (26.0 to 55.9) that is 500.63 to 1,077.47 a share, or 670.77 at its average P/E of 34.8. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 12.96 | 336.47 | 450.81 | 724.15 |
| FY2027 | 14.16 | 367.70 | 492.66 | 791.37 |
| FY2028 | 15.91 | 413.13 | 553.52 | 889.13 |
| FY2029 (extrapolated) | 17.52 | 454.78 | 609.33 | 978.78 |
| FY2030 (extrapolated) | 19.29 | 500.63 | 670.77 | 1,077.47 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 10.1% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (26.0, 34.8, 55.9).
Is IQVIA Holdings stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
IQVIA Holdings's P/E of 31.8 is around the middle of its 5-year range (18.5 to 70.6, median 32.0). It is in line with its own history. Buyers pay more for each point of growth than usual: a PEG of 1.2 on expected growth against 0.8 on its median P/E and past five years' growth. At its usual P/E (31.6 × EPS of 8.32), IQVIA Holdings's fair value is 263.24, close to the price of 264.96. Its forward P/E, on the consensus for FY2026, is 20.4.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (18.5 and 50.0). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 31.85
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 32.01
- Five-year P/E range
- 18.5 – 70.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 20.44
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.16
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +10.0%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.760 | 71.4258Price 35.76193 | +99.7% | |
| 29.080 | 56.2434Price 29.0896 | +93.4% | |
| 240.360 | 464.26205Price 240.36627 | +93.2% | |
| 202.040 | 384.58163Price 202.042,644 | +90.3% | |
| 161.340 | 305.52160Price 161.34396 | +89.4% | |
| 125.395 | 237.44178Price 125.40297 | +89.4% | |
| 159.580 | 300.48225Price 159.58376 | +88.3% |
Furthest below the fair value on each stock's page, updated every day.